Recent Updates
Recently added Catalysts
AMGN Positive Sentiment Score: 70/100

AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

Wednesday, February 25, 2026 2 min read
Key Takeaway: Amgen will present at the 46th Annual TD Cowen Health Care Conference on March 2, 2026. Senior executives Kave Niksefat and Justin Claeys will lead the presentation, which will be available via webcast for media and investors. The event underscores Amgen's ongoing commitment to innovation and communication with stakeholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Amgen is actively engaging with investors at a prominent conference.
  • The company showcases its commitment to transparency through webcasts.
  • Amgen's innovative pipeline is highlighted, indicating strong future potential.

Full Press Release Details

THOUSAND OAKS, Calif.,Feb. 24, 2026/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 46thAnnual TD Cowen Health Care Conference at 1:10 p.m. ET on Monday, March 2, 2026. Kave Niksefat, senior vice president of Global Marketing and Access at Amgen, and Justin Claeys, senior vice president of Finance at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website,www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About AmgenAmgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases and obesity and obesity-related conditions.
Amgen has beenconsistently recognizedfor innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visitAmgen.comand follow Amgen onX,LinkedIn,Instagram,YouTube,Facebook,TikTokandThreads.
CONTACT: Amgen, Thousand OaksElissa Snook, 609-251-1407 (media)Casey Capparelli, 805-447-1746 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-46th-annual-td-cowen-health-care-conference-302696171.html
SOURCE Amgen

Frequently Asked Questions

When will Amgen present at the conference?

Amgen will present at the conference on March 2, 2026, at 1:10 p.m. ET.

Who will represent Amgen at the conference?

Kave Niksefat and Justin Claeys will represent Amgen during the presentation.

How can I access the conference webcast?

The webcast will be available on Amgen's website and can be accessed by the public.

What topics will Amgen discuss at the conference?

Amgen will discuss its innovative medicines and business developments.

Tags: AMGN Viatris Investor Conferences Healthcare Amgen TD Cowen health care conference investor relations biotechnology
Last updated: Feb 25, 2026